nach oben

Inflammation

Erschienen in:

01.06.2014

Assessing Disease Severity and Activity in Patients with Familial Mediterranean Fever

verfasst von: S. Kapoor

Erschienen in: Inflammation | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Excerpt

To The Editor: Ahsen et al. have provided interesting data in their recent article in your esteemed journal [1]. Interestingly, the past few years have seen the identification of other sensitive markers to assess disease severity and activity in patients with familial Mediterranean fever (FMF). …

Ahsen A, Ulu MS, Yuksel S, et al. 2014. As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation:1–6 (in press).

Meijer, B., R. Gearry, and A. Day. 2012. The role of S100A12 as a systemic marker of inflammation. International journal of inflammation 2012: 6.CrossRef

Giese, A., Kurucay, M., Kilic, L., et al. 2012. Quality of life in adult patients with Familial Mediterranean fever living in Germany or Turkey compared to healthy subjects: a study evaluating the effect of disease severity and country of residence. Rheumatology International:1–7.

Aslan, D. 2013. Leukopenia in familial Mediterranean fever: case series and literature review with special emphasis on pathogenesis. Pediatric Hematology-Oncology 30: 717–722.CrossRef

Doria, A., et al. 2012. Autoinflammation and autoimmunity: bridging the divide. Autoimmunity reviews 12(1): 22–30.CrossRef

Kallinich, Tilmann, et al. 2010. Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever. Annals of the rheumatic diseases 69(4): 677–682.PubMedCrossRef

Henderson, Cailin, and Raphaela Goldbach-Mansky. 2010. Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis. Current opinion in rheumatology 22(5): 567.PubMedCentralPubMed

Makay, Balahan, Özer Makay, and Erbil Ünsal. 2009. Can we use faecal calprotectin to distinguish abdominal pain of familial Mediterranean fever (FMF) from acute appendicitis? Clinical rheumatology 28(2): 239–240.PubMedCrossRef

Dzhndoyan, Z.T. 2012. Serum levels of myeloid-related protein mrp 8/14 (calprotectin) en Armenian patients with familial Mediterranean fever (fmf). TERAPEVTICHESKII ARKHIV 84(6): 45–48.

10.

Oncu, Kemal, et al. “2013. Can serum fetuin-A be regarded as an inflammatory marker among patients with familial Mediterranean fever?.” Digestive diseases and sciences 58: 3212–3217.

11.

Sari, Ismail, et al. 2012. The effect of regular colchicine treatment on biomarkers related with vascular injury in newly diagnosed patients with familial Mediterranean fever. Inflammation 35(3): 1191–1197.PubMedCrossRef

12.

Sakallı, Hale, and Öznur Kal. 2013. “Mean platelet volume as a potential predictor of proteinuria and amyloidosis in familial Mediterranean fever.” Clinical rheumatology 32: 1185–1190.

13.

Hemminki, Kari, et al. 2013. Incidence of hereditary amyloidosis and autoinflammatory diseases in Sweden: endemic and imported diseases. BMC Medical Genetics 14(1): 88.PubMedCentralPubMedCrossRef

14.

Deveci, K., A. Gokakin, S. Senel, H. Deveci, A. Uslu, and E. Sancakdar. 2013. Cystatin C in serum as an early marker of renal involvement in familial Mediterranean fever patients. European Review for Medical and Pharmacological Sciences 17: 253–260.PubMed

15.

Obici, L., and G. Merlini. 2012. AA amyloidosis: basic knowledge, unmet needs and future treatments. Swiss Medical Weekly 142: w13580.PubMed

Titel: Assessing Disease Severity and Activity in Patients with Familial Mediterranean Fever
verfasst von: S. Kapoor
Publikationsdatum: 01.06.2014
Verlag: Springer US
Erschienen in: Inflammation / Ausgabe 3/2014
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-013-9803-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Assessing Disease Severity and Activity in Patients with Familial Mediterranean Fever

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

Punicalagin Inhibits Inflammation in LPS-Induced RAW264.7 Macrophages via the Suppression of TLR4-Mediated MAPKs and NF-κB Activation

Myeloid-Derived Suppressor Cells Protect Mouse Models from Autoimmune Arthritis via Controlling Inflammatory Response

IL-33 Neutralization Suppresses Lupus Disease in Lupus-Prone Mice

Diverse Influences of Androgen-Disrupting Chemicals on Immune Responses Mounted by Macrophages

Aging Reduces the Expression of Lung CINC and MCP-1 mRNA in a P. aeruginosa Rat Model of Infection

Inhibition of PI3Kδ Improves Systemic Lupus in Mice

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin